Sfoglia per Autore NOZZA, SILVIA
Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients
2004-01-01 Hasson, H; Gianotti, N; Danise, A; Seminari, E; Boeri, E; Nozza, S; Castagna, Antonella; Lazzarin, A.
Influence of gender in predicting CCR5 coreceptor usage
2008-01-01 Nozza, S; Soria, A; Visco, F; Vinci, C; Cossarini, F; Spagnuolo, V; Barda, B; Torre, L Della; Castagna, A; Lazzarin, A; Galli, L; Tambussi, G
Persistence of CCR5 usage among primary human immunodeficiency virus isolates of individuals receiving intermittent interleukin-2
2010-01-01 Ghezzi, S.; Pacciarini, F.; Nozza, S.; Racca, S.; Mariani, S. A.; Vicenzi, E.; Lazzarin, A.; Veglia, F.; Tambussi, G.; Poli, Guido
Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience
2010-01-01 Nozza, Silvia; Galli, Laura; Visco, Francesca; Soria, Alessandro; Canducci, Filippo; Salpietro, Stefania; Gianotti, Nicola; Bigoloni, Alba; Della Torre, Liviana; Tambussi, Giuseppe; Lazzarin, Adriano; Castagna, Antonella
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism
2010-01-01 Siccardi, Marco; D'Avolio, Antonio; Nozza, Silvia; Simiele, Marco; Baietto, Lorena; Stefani, Francesca Romana; Moss, Darren; Kwan, Wai san; Castagna, Antonella; Lazzarin, Adriano; Calcagno, Andrea; Bonora, Stefano; Back, David; Di Perri, Giovanni; Owen, Andrew
Durability of a novel salvage therapy in R5 HIV-infected patients: maraviroc, raltegravir, etravirine
2010-01-01 Nozza, S; Bigoloni, A; Galli, L; Gianotti, N; Pogliaghi, M; Cossarini, F; Salpietro, S; Galli, A; Della Torre, L; Tambussi, G; Lazzarin, A; Castagna, A
Pharmacokinetics of the raltegravir/maraviroc/etravirine combination
2011-01-01 Calcagno, Andrea; Nozza, Silvia; Bonora, Stefano; Castagna, Antonella; de Requena Daniel, Gonzalez; D'Avolio, Antonio; Lazzarin, Adriano; Di Perri, Giovanni
Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients
2011-01-01 Gianotti, N.; Visco, F.; Galli, L.; Barda, B.; Piatti, P.; Salpietro, S.; Bigoloni, A.; Vinci, C.; Nozza, S.; Gallotta, G.; Lazzarin, A.; Castagna, A.
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption
2011-01-01 Canducci, F; Barda, B; Ceresola, E; Spagnuolo, Vincenzo; Sampaolo, M; Boeri, E; Nozza, S; Cossarin, F; Galli, A; Gianotti, N; Castagna, Antonella; Lazzarin, Adriano; Clementi, Massimo
Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: Maraviroc, raltegravir, etravirine
2011-01-01 Nozza, S.; Galli, L.; Bigoloni, A.; Nicola, G.; Pogliaghi, M.; Cossarini, F.; Salpietro, S.; Galli, A.; Torre, L. D.; Tambussi, G.; Lazzarin, A.; Castagna, A.
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts
2012-01-01 Nozza, Silvia; Canducci, Filippo; Galli, Laura; Cozzi Lepri, Alessandro; Capobianchi Maria, Rosaria; Ceresola Elisa, Rita; Narciso, Pasquale; Libertone, Raffaella; Castelli, Paula; Moioli, Mariacristina; Monforte A., D'Arminio; Castagna, Antonella
The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection.
2012-01-01 Marcotullio, S; Andreoni, M; Antinori, A; d'Arminio Monforte, A; Di Perri, G; Galli, M; Ippolito, G; Perno, C. F.; Rizzardini, G; Lazzarin, Adriano; Cinque, P; Fares, G; Foglia, E; Gervasoni, C; Murri, R; Nozza, S; Rusconi, S.
Immune recovery and T cell subset analysis during effective treatment with maraviroc
2012-01-01 Cossarini, F; Galli, A; Galli, L; Bigoloni, A; Salpietro, S; Vinci, C; Della Torre, L; Gianotti, N; Spagnuolo, Vincenzo; Lazzarin, Adriano; Castagna, Antonella; Nozza, S.
Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens
2012-01-01 Bigoloni, A; Gianotti, N; Spagnuolo, Vincenzo; Galli, L; Nozza, S; Cossarini, F; Salpietro, S; Carini, E; Piatti, P; Vinci, C; Lazzarin, Adriano; Castagna, Antonella
Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients.
2012-01-01 Nozza, S; Pogliaghi, M; Chiappetta, S; Spagnuolo, Vincenzo; Fontana, G; Razzari, C; Tambussi, G; Faioni, Em
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA Study Group
2012-01-01 Svicher, V; Alteri, C; Montano, M; D'Arrigo, R; Andreoni, M; Angarano, G; Antinori, A; Antonelli, G; Allice, T; Bagnarelli, P; Baldanti, F; Bertoli, A; Borderi, M; Boeri, E; Bon, I; Bruzzone, B; Callegaro, Ap; Capobianchi, Mr; Carosi, G; Cauda, R; Ceccherini Silberstein, F; Clementi, Massimo; Chirianni, A; Colafigli, M; Monforte, Ad; De Luca, A; Di Biagio, A; Di Nicuolo, G; Di Perri, G; Di Pietro, M; Di Santo, F; Fabeni, L; Fadda, G; Galli, M; Gennari, W; Ghisetti, V; Giacometti, A; Gori, C; Gori, A; Gulminetti, R; Leoncini, F; Maffongelli, G; Maggiolo, F; Manca, G; Gargiulo, F; Martinelli, C; Maserati, R; Mazzotta, F; Meini, G; Micheli, V; Monno, L; Mussini, C; Narciso, P; Nozza, S; Paolucci, S; Palu, G; Parisi, S; Parruti, G; Pignataro, Ar; Pollicita, M; Quirino, T; Re, Mc; Rizzardini, G; Santangelo, R; Scaggiante, R; Sterrantino, G; Turriziani, O; Vatteroni, Ml; Vecchi, L; Viscoli, C; Vullo, V; Zazzi, M; Lazzarin, Adriano; Perno, Cf
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses
2012-01-01 Malnati, Ms; Heltai, S; Cosma, A; Reitmeir, P; Allgayer, S; Glashoff, Rh; Liebrich, W; Vardas, E; Imami, N; Westrop, S; Nozza, S; Tambussi, G; Butto, S; Fanales Belasio, E; Ensoli, B; Ensoli, F; Tripiciano, A; Fortis, C; Lusso, P; Poli, Guido; Erfle, V; Holmes, H.
Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient
2013-01-01 Ripa, Marco; Chiappetta, Stefania; Nozza, Silvia
B-cell subset alterations and correlated factors in HIV-1 infection
2013-01-01 Pensieroso, Simone; Galli, Laura; Nozza, Silvia; Ruffin, Nicolas; Castagna, Antonella; Tambussi, Giuseppe; Hejdeman, Bo; Misciagna, Donatella; Riva, Agostino; Malnati, Mauro; Chiodi, Francesca; Scarlatti, Gabriella
Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection
2014-01-01 Nozza, Silvia; Bigoloni, Alba; Calcagno, Andrea; Galli, Laura; Pignataro Angela, Rosa; D'Avolio, Antonio; Carbone, Alessia; Ripa, Marco; Bonora, Stefano; Lazzarin, Adriano; Castagna, Antonella
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients | 1-gen-2004 | Hasson, H; Gianotti, N; Danise, A; Seminari, E; Boeri, E; Nozza, S; Castagna, Antonella; Lazzarin, A. | |
| Influence of gender in predicting CCR5 coreceptor usage | 1-gen-2008 | Nozza, S; Soria, A; Visco, F; Vinci, C; Cossarini, F; Spagnuolo, V; Barda, B; Torre, L Della; Castagna, A; Lazzarin, A; Galli, L; Tambussi, G | |
| Persistence of CCR5 usage among primary human immunodeficiency virus isolates of individuals receiving intermittent interleukin-2 | 1-gen-2010 | Ghezzi, S.; Pacciarini, F.; Nozza, S.; Racca, S.; Mariani, S. A.; Vicenzi, E.; Lazzarin, A.; Veglia, F.; Tambussi, G.; Poli, Guido | |
| Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience | 1-gen-2010 | Nozza, Silvia; Galli, Laura; Visco, Francesca; Soria, Alessandro; Canducci, Filippo; Salpietro, Stefania; Gianotti, Nicola; Bigoloni, Alba; Della Torre, Liviana; Tambussi, Giuseppe; Lazzarin, Adriano; Castagna, Antonella | |
| Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism | 1-gen-2010 | Siccardi, Marco; D'Avolio, Antonio; Nozza, Silvia; Simiele, Marco; Baietto, Lorena; Stefani, Francesca Romana; Moss, Darren; Kwan, Wai san; Castagna, Antonella; Lazzarin, Adriano; Calcagno, Andrea; Bonora, Stefano; Back, David; Di Perri, Giovanni; Owen, Andrew | |
| Durability of a novel salvage therapy in R5 HIV-infected patients: maraviroc, raltegravir, etravirine | 1-gen-2010 | Nozza, S; Bigoloni, A; Galli, L; Gianotti, N; Pogliaghi, M; Cossarini, F; Salpietro, S; Galli, A; Della Torre, L; Tambussi, G; Lazzarin, A; Castagna, A | |
| Pharmacokinetics of the raltegravir/maraviroc/etravirine combination | 1-gen-2011 | Calcagno, Andrea; Nozza, Silvia; Bonora, Stefano; Castagna, Antonella; de Requena Daniel, Gonzalez; D'Avolio, Antonio; Lazzarin, Adriano; Di Perri, Giovanni | |
| Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients | 1-gen-2011 | Gianotti, N.; Visco, F.; Galli, L.; Barda, B.; Piatti, P.; Salpietro, S.; Bigoloni, A.; Vinci, C.; Nozza, S.; Gallotta, G.; Lazzarin, A.; Castagna, A. | |
| Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption | 1-gen-2011 | Canducci, F; Barda, B; Ceresola, E; Spagnuolo, Vincenzo; Sampaolo, M; Boeri, E; Nozza, S; Cossarin, F; Galli, A; Gianotti, N; Castagna, Antonella; Lazzarin, Adriano; Clementi, Massimo | |
| Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: Maraviroc, raltegravir, etravirine | 1-gen-2011 | Nozza, S.; Galli, L.; Bigoloni, A.; Nicola, G.; Pogliaghi, M.; Cossarini, F.; Salpietro, S.; Galli, A.; Torre, L. D.; Tambussi, G.; Lazzarin, A.; Castagna, A. | |
| Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts | 1-gen-2012 | Nozza, Silvia; Canducci, Filippo; Galli, Laura; Cozzi Lepri, Alessandro; Capobianchi Maria, Rosaria; Ceresola Elisa, Rita; Narciso, Pasquale; Libertone, Raffaella; Castelli, Paula; Moioli, Mariacristina; Monforte A., D'Arminio; Castagna, Antonella | |
| The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection. | 1-gen-2012 | Marcotullio, S; Andreoni, M; Antinori, A; d'Arminio Monforte, A; Di Perri, G; Galli, M; Ippolito, G; Perno, C. F.; Rizzardini, G; Lazzarin, Adriano; Cinque, P; Fares, G; Foglia, E; Gervasoni, C; Murri, R; Nozza, S; Rusconi, S. | |
| Immune recovery and T cell subset analysis during effective treatment with maraviroc | 1-gen-2012 | Cossarini, F; Galli, A; Galli, L; Bigoloni, A; Salpietro, S; Vinci, C; Della Torre, L; Gianotti, N; Spagnuolo, Vincenzo; Lazzarin, Adriano; Castagna, Antonella; Nozza, S. | |
| Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens | 1-gen-2012 | Bigoloni, A; Gianotti, N; Spagnuolo, Vincenzo; Galli, L; Nozza, S; Cossarini, F; Salpietro, S; Carini, E; Piatti, P; Vinci, C; Lazzarin, Adriano; Castagna, Antonella | |
| Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients. | 1-gen-2012 | Nozza, S; Pogliaghi, M; Chiappetta, S; Spagnuolo, Vincenzo; Fontana, G; Razzari, C; Tambussi, G; Faioni, Em | |
| Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA Study Group | 1-gen-2012 | Svicher, V; Alteri, C; Montano, M; D'Arrigo, R; Andreoni, M; Angarano, G; Antinori, A; Antonelli, G; Allice, T; Bagnarelli, P; Baldanti, F; Bertoli, A; Borderi, M; Boeri, E; Bon, I; Bruzzone, B; Callegaro, Ap; Capobianchi, Mr; Carosi, G; Cauda, R; Ceccherini Silberstein, F; Clementi, Massimo; Chirianni, A; Colafigli, M; Monforte, Ad; De Luca, A; Di Biagio, A; Di Nicuolo, G; Di Perri, G; Di Pietro, M; Di Santo, F; Fabeni, L; Fadda, G; Galli, M; Gennari, W; Ghisetti, V; Giacometti, A; Gori, C; Gori, A; Gulminetti, R; Leoncini, F; Maffongelli, G; Maggiolo, F; Manca, G; Gargiulo, F; Martinelli, C; Maserati, R; Mazzotta, F; Meini, G; Micheli, V; Monno, L; Mussini, C; Narciso, P; Nozza, S; Paolucci, S; Palu, G; Parisi, S; Parruti, G; Pignataro, Ar; Pollicita, M; Quirino, T; Re, Mc; Rizzardini, G; Santangelo, R; Scaggiante, R; Sterrantino, G; Turriziani, O; Vatteroni, Ml; Vecchi, L; Viscoli, C; Vullo, V; Zazzi, M; Lazzarin, Adriano; Perno, Cf | |
| A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses | 1-gen-2012 | Malnati, Ms; Heltai, S; Cosma, A; Reitmeir, P; Allgayer, S; Glashoff, Rh; Liebrich, W; Vardas, E; Imami, N; Westrop, S; Nozza, S; Tambussi, G; Butto, S; Fanales Belasio, E; Ensoli, B; Ensoli, F; Tripiciano, A; Fortis, C; Lusso, P; Poli, Guido; Erfle, V; Holmes, H. | |
| Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient | 1-gen-2013 | Ripa, Marco; Chiappetta, Stefania; Nozza, Silvia | |
| B-cell subset alterations and correlated factors in HIV-1 infection | 1-gen-2013 | Pensieroso, Simone; Galli, Laura; Nozza, Silvia; Ruffin, Nicolas; Castagna, Antonella; Tambussi, Giuseppe; Hejdeman, Bo; Misciagna, Donatella; Riva, Agostino; Malnati, Mauro; Chiodi, Francesca; Scarlatti, Gabriella | |
| Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection | 1-gen-2014 | Nozza, Silvia; Bigoloni, Alba; Calcagno, Andrea; Galli, Laura; Pignataro Angela, Rosa; D'Avolio, Antonio; Carbone, Alessia; Ripa, Marco; Bonora, Stefano; Lazzarin, Adriano; Castagna, Antonella |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile